MOLMED (EGFF)
Signed · Italy
Source: European Investment Bank (EIB)
The Project will finance the RDI activities of the Promoter to develop innovative anti-cancer and rare diseases treatments in the field of cell and gene therapy, during the investment period 2019-2022.
- Status
- Under Construction
- Sector
- Hospital, Government
- Location
- Italy
- Updated
- 22 Jul 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about MOLMED (EGFF)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | signed |
Taiyo status | Under Construction |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | The Project will finance the RDI activities of the Promoter to develop innovative anti-cancer and rare diseases treatments in the field of cell and gene therapy, during the investment period 2019-2022. |
Original sector | Services |
Location
Country | Italy |
Source
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Hospital, Government |
Article published date | 2025-07-28 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Hospital projects in Italy
- Catalent’s Covid-19 Vaccine Manufacturing Facility, Anagni
- Indena Anti-Cancer Compound Plant Automation
- MOTIGRAVITY Treadmill
- SAG clinical validation
- BYHOURS HOTEL MICROSTAYS
- Catalent’s Biologics Manufacturing Facility Expansion, Anagni, Italy
- Lonza’s Bioconjugation Facility Expansion, Visp
- Lonza’s Ibex Biomanufacturing Complex, Visp, Switzerland
